Dopaminergic degeneration induces early posterior cortical thinning in Parkinson's disease
Background: Cognitive decline in Parkinson's disease (PD) is a highly prevalent condition with no effective treatment. Cortical atrophy is thought to promote its development but to design optimal therapeutic approaches in this clinical setting we need to understand the physiopathological mechan...
Main Authors: | Frederic Sampedro, Juan Marín-Lahoz, Saul Martínez-Horta, Javier Pagonabarraga, Jaime Kulisevsky |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-04-01
|
Series: | Neurobiology of Disease |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0969996118305448 |
Similar Items
-
Asymmetric Dopaminergic Degeneration and Attentional Resources in Parkinson’s Disease
by: Paola Ortelli, et al.
Published: (2018-12-01) -
Early Gray Matter Volume Loss in MAPT H1H1 de Novo PD Patients: A Possible Association With Cognitive Decline
by: Frederic Sampedro, et al.
Published: (2018-05-01) -
Abnormal subcortical volumes and cortical thickness in Parkinson's disease with impulse control disorders
by: Shweta Prasad, et al.
Published: (2019-01-01) -
Clinical Features Indicating Nigrostriatal Dopaminergic Degeneration in Drug-Induced Parkinsonism
by: Seung Ha Lee, et al.
Published: (2017-01-01) -
The impact of dopaminergic treatment over cognitive networks in Parkinson's disease: Stemming the tide?
by: Aracil-Bolaños, I., et al.
Published: (2021)